Data integration into a singular database
Ashfield Pharmacovigilance develops comprehensive strategic plan for client involved in database merger to ensure successful continuation of case processing and reporting while maintaining both databases.
Pharmacovigilance preparation for product launch
Insight Our client, a fast growing company, had recently received recommendation for approval by the FDA Advisory Committee and needed to show the FDA they had the infrastructure... read more
E-submissions through the FDA portal
Insight The FDA was requiring e-submissions be set up through the FDA portal. Ashfield Pharmacovigilance determined that this process would take approximately four hours per client. Seventeen clients... read more